HME-assisted formulation of taste-masked dispersible tablets of cefpodoxime proxetil and roxithromycin.

Objectives: Antibiotics are the most commonly administered medications among pediatric patients. However most of the time, accurate dose administration to children becomes a problem due to the extremely bitter taste. Cefpodoxime proxetil (CP) and roxithromycin (ROX) are antibiotics often prescribed to the pediatric population and have a bitter taste. Marketed formulations of these drugs are dry suspension and/or tablets. The lyophilization method involves various steps and thus is time consuming and expensive. The objective of this study was to mask the bitter taste of CP and ROX without compromising the solubility and drug release profile compared to marketed formulations, as well as to overcome the disadvantages associated with the currently used lyophilization technique. Methods: Hot melt extrusion (HME) technology was used to process CP and ROX individually with Eudragit E PO polymer. The extrudates obtained were characterized by Fourier transform infrared spectroscopy, powder X-ray diffraction, and differential scanning calorimetry. The powdered extrudates were formulated as dispersible tablets and evaluated for in vitro and in vivo taste-masking efficiency. Results: The tablets prepared in this study showed comparable dissolution profiles but the taste-masking efficiency was significantly enhanced compared to the marketed tablets of CP and ROX. The results of in vivo human taste-masking evaluation were also in agreement with the in vitro taste-masking studies. Conclusion: The current work presents solvent-free, scalable, and continuous HME technology for addressing the bitter taste issues of CP and ROX. The disadvantages associated with the currently used lyophilization technique were overcome by developing the formulations using HME technology.

Low-Temperature controlled synthesis of nanocast mixed metal oxide spinels for enhanced OER activity.

The controlled cation substitution is an effective strategy for optimizing the density of states and enhancing the electrocatalytic activity of transition metal oxide catalysts for water splitting. However, achieving tailored mesoporosity while maintaining elemental homogeneity and phase purity remains a significant challenge, especially when aiming for complex multi-metal oxides. In this study, we utilized a one-step impregnation nanocasting method for synthesizing mesoporous Mn-, Fe-, and Ni-substituted cobalt spinel oxide (Mn0.1Fe0.1Ni0.3Co2.5O4, MFNCO) and demonstrate the benefits of low-temperature calcination within a semi-sealed container at 150-200 °C. The comprehensive discussion of calcination temperature effects on porosity, particle size, surface chemistry and catalytic performance for the alkaline oxygen evolution reaction (OER) highlights the importance of humidity, which was modulated by a pre-drying step. The catalyst calcined at 170 °C exhibited the lowest overpotential (335 mV at 10 mA cm-2), highest current density (433 mA cm-2 at 1.7 V vs. RHE, reversible hydrogen electrode) and further displayed excellent stability over 22 h (at 10 mA cm-2). Furthermore, we successfully adapted this method to utilize cheap, commercially available silica gel as a hard template, yielding comparable OER performance. Our results represent a significant progress in the cost-efficient large-scale preparation of complex multi-metal oxides for catalytic applications.

Biocompatible arabinogalactan-chitosan scaffolds for photothermal pharmacology in wound healing and tissue regeneration.

Delayed wound healing is often caused by bacterial infections and persistent inflammation. Multifunctional materials with anti-bacterial, anti-inflammatory, and hemostatic properties are crucial for accelerated wound healing. In this study, we report a biomacromolecule-based scaffold (ArCh) by uniquely combining arabinogalactan (Ar) and chitosan (Ch) using a Schiff-based reaction. Further, the optimized ArCh scaffolds were loaded with Glycyrrhizin (GA: anti-inflammatory molecule) conjugated NIR light-absorbing Copper sulfide (CuS) nanoparticles. The resultant GACuS ArCh scaffolds were characterized for different wound healing parameters in in-vitro and in-vivo models. Our results indicated that GACuS ArCh scaffolds showed excellent swelling, biodegradation, and biocompatibility in vitro. Further results obtained indicated that GACuS ArCh scaffolds demonstrated mild hyperthermia and enhanced hemostatic, anti-oxidant, anti-bacterial, and wound-healing effects when exposed to NIR light. The scaffolds, upon further validation, may be beneficial in accelerating wound healing and tissue regeneration response.